Molecular response to first line nilotinib in a patient with e19a2 BCR–ABL1 chronic myeloid leukemia
Stephen E. Langabeer, Sarah L. McCarron, Peig Carroll, Johanna Kelly, Michael O’Dwyer, Eibhlin ConneallyVolume:
35
Year:
2011
Language:
english
Pages:
1
DOI:
10.1016/j.leukres.2011.05.010
File:
PDF, 138 KB
english, 2011